Trials / Completed
CompletedNCT04910607
Social and Psychological Impacts of SARS-Cov-2 Pandemic Period in the Obese Population.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 279 (actual)
- Sponsor
- University Hospital, Bordeaux · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The population suffering from obesity is particularly at risk during this pandemic period. The Nouvelle Aquitaine region is not spared, since according to the regional epidemiological report of 7 May 2020, carried out by Santé Publique France, 39.2% of cases admitted to the intensive care unit in Nouvelle Aquitaine and presenting risk factors are overweight or obese. Other risk factors, such as social-environmental factors, must be taken into consideration. Socio-demographic surveys in this area highlight the socio-economic and territorial inequalities that interfere with obesity issues. Similarly, the issues of stigmatisation and isolation seem to be at the heart of the question of how to deal with these people.
Detailed description
This is a prospective multicentre study. Participating patients will be recruited from the Specialised Obesity Centres (CHU and SSR, as well as patient associations) to fill in a questionnaire and take part in an interview (a varied panel representative of the target population in terms of place of residence, socio-professional category, sex and age). The medical and paramedical staff involved in the partner CSOs and the patients' resources (identified by the patients' associations) will also be asked to participate in a semi-directive interview.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Questionnaire | Questionnaire with 4 axes: sociological, reflexive medical, prospective medical, transversal |
| OTHER | Interview | Interview concerning health pathways, experience of confinement, consequences of confinement on health, representations of obesity. |
Timeline
- Start date
- 2022-01-21
- Primary completion
- 2023-07-28
- Completion
- 2023-07-28
- First posted
- 2021-06-02
- Last updated
- 2024-01-02
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04910607. Inclusion in this directory is not an endorsement.